10:15 am Making MASH a Strategic & Commercial Priority to Advance Next-Gen Therapies for More Effective Drug Development
Time: 10:15 am
day: Conf Day 1
Details:
- Addressing the MASH opportunity to emphasize the crucial role of synergistic novel scientific approaches and strategic collaborative partnerships to drive the development of the next generation of effective therapies
- Prioritizing a review for next-generation therapies to understand the most promising emerging therapeutic avenues, including cell-based therapies and combination approaches, to strategically advance the future of MASH treatment, improve patient outcomes, and enhance commercial viability
- Exploring novel strategies and regulatory advancements to advance innovation and market access to accelerate processes, optimize resource allocation, secure a broad spectrum of MASH treatment options for patients, and facilitate market penetration
